Science Explorer Back to mapMap
Discussion
Company · Villeurbanne · France

Covalab (France)

Research works
11
▼ 53% vs 2018-21
Citations
225
20.8 per fractional work
Top-10% rate
16.5%
all institutions 10.0%
Open access
53%
world 40%
International
53%
world 18%

Not ranked overall: Covalab (France) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Covalab (France) work in?

In all years, 70% of research at Covalab (France) is in Health Sciences, 21% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (18%), Social Sciences (5%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 69.5% of its workMedicine: 7 fractional works · 67.2% of its workPulmonary and Respiratory Medicine: 3 fractional works · 30.4% of its workPhysiology: 1 fractional works · 6.7% of its workHematology: 1 fractional works · 5.6% of its workSurgery: 1 fractional works · 5.4% of its workEpidemiology: 1 fractional works · 4.9% of its workGastroenterology: 0 fractional works · 4.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 4.3% of its workOrthopedics and Sports Medicine: 0 fractional works · 3.0% of its workUrology: 0 fractional works · 1.0% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workOncology: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 2.3% of its workGeneral Health Professions: 0 fractional works · 2.3% of its workLife Sciences: 2 fractional works · 20.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 17.7% of its workMolecular Biology: 1 fractional works · 9.4% of its workCell Biology: 1 fractional works · 8.0% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 2.5% of its workImmunology: 0 fractional works · 2.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workFood Science: 0 fractional works · 0.6% of its workSocial Sciences: 1 fractional works · 9.2% of its workSocial Sciences: 0 fractional works · 4.6% of its workCultural Studies: 0 fractional works · 1.6% of its workPolitical Science and International Relations: 0 fractional works · 1.6% of its workSociology and Political Science: 0 fractional works · 1.6% of its workBusiness, Management and Accounting: 0 fractional works · 3.0% of its workManagement of Technology and Innovation: 0 fractional works · 1.6% of its workMarketing: 0 fractional works · 1.6% of its workArts and Humanities: 0 fractional works · 1.6% of its workLiterature and Literary Theory: 0 fractional works · 1.6% of its workPhysical Sciences: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workRadiation: 0 fractional works · 0.4% of its workALL ITS WORKCovalab (France)11fractional works, all years
Life Sciences21%Physical Sciences0%Health Sciences70%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine767.2%
    2. Health Professions02.3%
    1. Biochemistry, Genetics and Molecular Biology217.7%
    2. Immunology and Microbiology02.5%
    3. Agricultural and Biological Sciences00.6%
    1. Social Sciences04.6%
    2. Business, Management and Accounting03.0%
    3. Arts and Humanities01.6%
    1. Physics and Astronomy00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Covalab (France)?

Ranked on the quality score, Saı̈d El Alaoui lead among researchers whose main affiliation is Covalab (France).

  1. 1 Saı̈d El Alaoui France · #1,999,454 worldwide 981 citations · 34 works
All ranked researchers at Covalab (France)

What are the most cited papers from Covalab (France)?

The most cited paper from Covalab (France) is "HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKα" (Anthea Di Rita, Angelo Peschiaroli, Pasquale D’Acunzo et al., 2018), with 295 citations. Next come "Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis" (170) and "Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy" (79).

Most cited papers
#PaperReleasedCitations
1 HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKα Anthea Di Rita, Angelo Peschiaroli, Pasquale D’Acunzo et al. · Nature Communications Open access 10 Sep 2018 295
2 Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis Pascale Grenard, Solange Bresson-Hadni, Saı̈d El Alaoui et al. · Journal of Hepatology Sep 2001 170
3 Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy Agathe Dubuisson, Olivier Micheau · Antibodies Open access 25 Oct 2017 79
4 Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions Eduard Badarau, Zejing Wang, Daniel L. Rathbone et al. · Chemistry & Biology Open access Oct 2015 56
5 Saturated and Unsaturated Fatty Acids Differently Modulate Colonic Goblet Cells In Vitro and in Rat Pups Bérengère Benoit, Jérémie Bruno, Fanny Kayal et al. · Journal of Nutrition Open access 25 Jun 2015 41
All 25 most cited papers, with filters and sorting

Which research topics does Covalab (France) publish most on?

By volume in 2022-now: Climate Change Communication and Perception, Ecocriticism and Environmental Literature, E-Government and Public Services and Posthumanist Ethics and Activism.

  1. 1 Climate Change Communication and Perception Sociology and Political Science 0 works
  2. 2 Ecocriticism and Environmental Literature Literature and Literary Theory 0 works
  3. 3 E-Government and Public Services Political Science and International Relations 0 works
  4. 4 Posthumanist Ethics and Activism Cultural Studies 0 works
  5. 5 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 0 works
  6. 6 Service and Product Innovation Marketing 0 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Protein purification and stability Molecular Biology 0 works
  9. 9 Blood properties and coagulation Pulmonary and Respiratory Medicine 0 works
  10. 10 HER2/EGFR in Cancer Research Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.3%not open46.7%

World: 40% of research is openly available.

with international co-authors52.7%domestic only47.3%

World: 18% is written across borders.

How has Covalab (France)'s research output changed?

Output in 2022-2025 was 53% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Covalab (France) as a percentage of every work published that year, 0.0000071% in 2024.

still counting0.000050%0.00010%Covalab (France)0.0000085% in 202520102020

Fractional works of Covalab (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Villeurbanne

All research institutions in Villeurbanne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Covalab (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.